Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.74	20.55	4.61	56.41	84.83	114.2
Short-Term Investments	101.83	119.63	46.49	-	-	-
Cash & Short-Term Investments	107.57	140.18	51.1	56.41	84.83	114.2
Cash Growth	28.66%	174.31%	-9.41%	-33.51%	-25.71%	1199.00%
Other Receivables	0.71	-	-	-	-	0.11
Receivables	0.71	-	-	-	-	0.11
Prepaid Expenses	3.12	2.82	4.94	3.08	3.48	1.29
Other Current Assets	0.01	0.73	0.09	0.03	0.03	0.04
Total Current Assets	111.4	143.73	56.13	59.52	88.35	115.63
Property, Plant & Equipment	0.77	0.93	0.37	0.74	0.77	0.14
Goodwill	-	-	-	-	48.65	48.65
Other Intangible Assets	32.39	32.39	32.39	32.39	32.39	32.39
Other Long-Term Assets	0.35	0.36	0.19	0.15	0.4	0.38
Total Assets	144.91	177.41	89.07	92.79	170.55	197.19
Accounts Payable	5.83	5.83	0.97	2.2	1.81	1.37
Accrued Expenses	7.55	5.43	2.55	3.91	2.22	0.97
Current Portion of Leases	0.34	0.31	0.38	0.36	0.37	0.14
Total Current Liabilities	13.72	11.58	3.9	6.48	4.4	2.48
Long-Term Leases	0.47	0.64	-	0.38	0.4	-
Long-Term Deferred Tax Liabilities	2.18	2.18	1.75	1.75	1.75	4.11
Other Long-Term Liabilities	22.51	44.87	76.21	-	-	-
Total Liabilities	38.88	59.27	81.86	8.61	6.55	6.59
Common Stock	0.06	0.06	0.02	0.01	0.01	0.02
Additional Paid-In Capital	423.62	473.64	326.59	287.03	278.88	270.97
Retained Earnings	-373.3	-355.59	-319.4	-202.87	-114.9	-80.39
Comprehensive Income & Other	-0.05	0.03	-	-	-	-
Total Common Equity	50.33	118.14	7.21	84.18	164	190.6
Shareholders' Equity	106.03	118.14	7.21	84.18	164	190.6
Total Liabilities & Equity	144.91	177.41	89.07	92.79	170.55	197.19
Total Debt	0.8	0.95	0.38	0.75	0.77	0.14
Net Cash (Debt)	106.77	139.22	50.72	55.66	84.06	114.05
Net Cash Growth	28.71%	174.50%	-8.88%	-33.78%	-26.29%	1247.01%
Net Cash Per Share	1.55	2.87	2.06	3.90	5.67	78.58
Filing Date Shares Outstanding	59.88	59.88	24.81	13.78	14.31	14.31
Total Common Shares Outstanding	59.88	59.79	24.21	13.78	14.31	15.16
Working Capital	97.69	132.15	52.23	53.04	83.95	113.15
Book Value Per Share	0.84	1.98	0.30	6.11	11.46	12.57
Tangible Book Value	17.95	85.75	-25.18	51.8	82.96	109.56
Tangible Book Value Per Share	0.30	1.43	-1.04	3.76	5.80	7.23

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q